BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 38635778)

  • 1. circTADA2A inhibited SLC38A1 expression and suppresses melanoma progression through the prevention of CNBP trans-activation.
    Zhang L; Zhang L; Zhang C; Shi S; Cao Z; Shao C; Li J; Yang Y; Zhang X; Wang J; Li X
    PLoS One; 2024; 19(4):e0301356. PubMed ID: 38635778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation.
    Yang F; Hu A; Li D; Wang J; Guo Y; Liu Y; Li H; Chen Y; Wang X; Huang K; Zheng L; Tong Q
    Mol Cancer; 2019 Nov; 18(1):158. PubMed ID: 31718709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression.
    Wu Y; Xie Z; Chen J; Chen J; Ni W; Ma Y; Huang K; Wang G; Wang J; Ma J; Shen S; Fan S
    Mol Cancer; 2019 Apr; 18(1):73. PubMed ID: 30940151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
    Li Z; Yao H; Wang S; Li G; Gu X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol disrupts cell carcinogenesis and aerobic glycolysis by regulating circTADA2A/miR-455-3p/FOXM1 axis in lung cancer.
    Zhao H; Wei H; He J; Wang D; Li W; Wang Y; Ai Y; Yang J
    Cell Cycle; 2020 Oct; 19(19):2538-2552. PubMed ID: 32857667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircRUNX1 functions as an oncogene in colorectal cancer by regulating circRUNX1/miR-485-5p/SLC38A1 axis.
    Yu J; Chen X; Li J; Wang F
    Eur J Clin Invest; 2021 Jul; 51(7):e13540. PubMed ID: 33769559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0084043-miR-134-5p axis regulates PCDH9 to suppress melanoma.
    Cai G; Zou R; Yang H; Xie J; Chen X; Zheng C; Luo S; Wei N; Liu S; Chen R
    Front Oncol; 2022; 12():891476. PubMed ID: 36387162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.
    Wang X; Chen T; Li C; Li W; Zhou X; Li Y; Luo D; Zhang N; Chen B; Wang L; Zhao W; Fu S; Yang Q
    J Hematol Oncol; 2022 Aug; 15(1):122. PubMed ID: 36038948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircFMN2 Boosts Sorafenib Resistance in Hepatocellular Carcinoma Cells via Upregulating CNBP by Restraining Ubiquitination.
    Fan C; Zhu X; Zhou Q; Wang W
    J Oncol; 2022; 2022():2674163. PubMed ID: 35909906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Amino Acid Transporter SNAT1/SLC38A1 in Human Melanoma.
    Böhme-Schäfer I; Lörentz S; Bosserhoff AK
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional roles of the circRNA/Wnt axis in cancer.
    Xue C; Li G; Zheng Q; Gu X; Bao Z; Lu J; Li L
    Mol Cancer; 2022 May; 21(1):108. PubMed ID: 35513849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Trends in Melanoma Detection Using Neural Networks: A Systematic Review.
    Popescu D; El-Khatib M; El-Khatib H; Ichim L
    Sensors (Basel); 2022 Jan; 22(2):. PubMed ID: 35062458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased incidence of melanoma in children and adolescents in Finland in 1990-2014: nationwide re-evaluation of histopathological characteristics.
    Rousi EK; Kallionpää RA; Kallionpää RE; Juteau SM; Talve LAI; Hernberg MM; Vihinen PP; Kähäri VM; Koskivuo IO
    Ann Med; 2022 Dec; 54(1):244-252. PubMed ID: 35037531
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.